Masimo Stock Price, News & Analysis (NASDAQ:MASI)

$86.68 +0.74 (+0.86 %)
(As of 02/16/2018 04:00 PM ET)
Previous Close$86.68
Today's Range$85.42 - $87.35
52-Week Range$79.81 - $104.71
Volume340,662 shs
Average Volume545,211 shs
Market Capitalization$4.52 billion
P/E Ratio13.74
Dividend YieldN/A
Beta0.85

About Masimo (NASDAQ:MASI)

Masimo logoMasimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.

Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNASDAQ:MASI
CUSIP57479510
Phone+1-949-2977000

Debt

Debt-to-Equity RatioN/A
Current Ratio3.17%
Quick Ratio2.59%

Price-To-Earnings

Trailing P/E Ratio13.7369255150555
Forward P/E Ratio29.38
P/E Growth3.27

Sales & Book Value

Annual Sales$694.63 million
Price / Sales6.45
Cash Flow$2.57 per share
Price / Cash33.75
Book Value$11.28 per share
Price / Book7.68

Profitability

Trailing EPS$6.31
Net Income$300.66 million
Net Margins45.83%
Return on Equity22.17%
Return on Assets16.60%

Miscellaneous

Employees1,243
Outstanding Shares51,670,000

Masimo (NASDAQ:MASI) Frequently Asked Questions

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) released its earnings results on Tuesday, October, 31st. The medical equipment provider reported $0.70 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.53 by $0.17. The medical equipment provider had revenue of $193.69 million for the quarter, compared to analysts' expectations of $189.01 million. Masimo had a net margin of 45.83% and a return on equity of 22.17%. Masimo's quarterly revenue was up 15.6% on a year-over-year basis. During the same quarter last year, the company earned $0.52 EPS. View Masimo's Earnings History.

When will Masimo make its next earnings announcement?

Masimo is scheduled to release their next quarterly earnings announcement on Tuesday, February, 27th 2018. View Earnings Estimates for Masimo.

Where is Masimo's stock going? Where will Masimo's stock price be in 2018?

5 brokers have issued 1-year target prices for Masimo's stock. Their forecasts range from $100.00 to $112.00. On average, they anticipate Masimo's share price to reach $106.25 in the next year. View Analyst Ratings for Masimo.

Are investors shorting Masimo?

Masimo saw a decrease in short interest during the month of January. As of January 12th, there was short interest totalling 876,332 shares, a decrease of 26.3% from the December 29th total of 1,189,834 shares. Based on an average daily volume of 463,935 shares, the days-to-cover ratio is currently 1.9 days. Approximately 1.8% of the company's shares are short sold.

Who are some of Masimo's key competitors?

Who are Masimo's key executives?

Masimo's management team includes the folowing people:

  • Joseph E. Kiani, Chairman of the Board, Chief Executive Officer (Age 52)
  • Micah Young, Chief Financial Officer, Executive Vice President
  • John Coleman, President - Worldwide Sales, Professional Services and Medical Affairs (Age 53)
  • Rick Fishel, President - Worldwide OEM Business & Strategic Development (Age 59)
  • Anand Sampath, Chief Operating Officer (Age 50)
  • Yongsam Lee, Executive Vice President, Chief Information Officer (Age 52)
  • Tom McClenahan, Executive Vice President, General Counsel, Corporate Secretary (Age 44)
  • Steven J. Barker M.D., Ph.D., Director (Age 72)
  • Sanford Fitch, Independent Director (Age 76)
  • Thomas Harkin, Independent Director (Age 77)

Who owns Masimo stock?

Masimo's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.03%), Acadian Asset Management LLC (2.04%), Bank of New York Mellon Corp (2.01%), Arrowstreet Capital Limited Partnership (1.93%), Robeco Institutional Asset Management B.V. (1.76%) and Old Mutual Global Investors UK Ltd. (1.71%). Company insiders that own Masimo stock include Anand Sampath, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo.

Who sold Masimo stock? Who is selling Masimo stock?

Masimo's stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Two Sigma Advisers LP, Robeco Institutional Asset Management B.V., BlackRock Inc., Renaissance Technologies LLC, Arrowstreet Capital Limited Partnership, Goldman Sachs Group Inc. and Allianz Asset Management GmbH. Company insiders that have sold Masimo company stock in the last year include Anand Sampath, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Insider Buying and Selling for Masimo.

Who bought Masimo stock? Who is buying Masimo stock?

Masimo's stock was acquired by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Schroder Investment Management Group, American Century Companies Inc., Victory Capital Management Inc., Wells Fargo & Company MN, Old Mutual Global Investors UK Ltd., APG Asset Management N.V. and MetLife Investment Advisors LLC. View Insider Buying and Selling for Masimo.

How do I buy Masimo stock?

Shares of Masimo can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Masimo's stock price today?

One share of Masimo stock can currently be purchased for approximately $86.68.

How big of a company is Masimo?

Masimo has a market capitalization of $4.52 billion and generates $694.63 million in revenue each year. The medical equipment provider earns $300.66 million in net income (profit) each year or $6.31 on an earnings per share basis. Masimo employs 1,243 workers across the globe.

How can I contact Masimo?

Masimo's mailing address is 52 Discovery, IRVINE, CA 92618-3105, United States. The medical equipment provider can be reached via phone at +1-949-2977000 or via email at [email protected]


MarketBeat Community Rating for Masimo (MASI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  211 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  409
MarketBeat's community ratings are surveys of what our community members think about Masimo and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Masimo (NASDAQ:MASI) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.572.572.57
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $106.25$97.00$97.00$97.00
Price Target Upside: 23.55% upside12.79% upside12.79% upside16.06% upside

Masimo (NASDAQ:MASI) Consensus Price Target History

Price Target History for Masimo (NASDAQ:MASI)

Masimo (NASDAQ:MASI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Stifel NicolausReiterated RatingBuy$108.00N/AView Rating Details
8/14/2017BTIG ResearchUpgradeNeutral -> Buy$100.00MediumView Rating Details
7/19/2017Roth CapitalBoost Price TargetBuy$96.00 -> $105.00LowView Rating Details
5/22/2017WedbushReiterated RatingOutperform$112.00LowView Rating Details
3/16/2017Piper Jaffray CompaniesDowngradeOverweight -> NeutralHighView Rating Details
2/13/2017Raymond James FinancialDowngradeOutperform -> Market PerformN/AView Rating Details
2/13/2017CitigroupDowngradeMarket Perform$60.00N/AView Rating Details
(Data available from 2/17/2016 forward)

Earnings

Masimo (NASDAQ:MASI) Earnings History and Estimates Chart

Earnings by Quarter for Masimo (NASDAQ:MASI)

Masimo (NASDAQ MASI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2018$0.61N/AView Earnings Details
10/31/2017Q3 2017$0.53$0.70$189.01 million$193.69 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.71$0.83$189.03 million$192.90 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.60$0.82$184.14 million$186.30 millionViewListenView Earnings Details
2/14/2017Q416$0.52$0.51$180.48 million$183.20 millionViewListenView Earnings Details
11/2/2016Q316$0.42$0.52$165.51 million$167.60 millionViewListenView Earnings Details
8/3/2016Q216$0.41$0.57$166.02 million$172.64 millionViewListenView Earnings Details
5/4/2016Q116$0.43$0.53$165.25 million$171.20 millionViewListenView Earnings Details
2/23/2016Q415$0.39$0.15$164.25 million$167.30 millionViewListenView Earnings Details
11/5/2015Q315$0.31$0.36$149.31 million$152.60 millionViewListenView Earnings Details
8/4/2015Q215$0.32$0.43$147.93 million$155.73 millionViewListenView Earnings Details
5/6/2015Q115$0.35$0.41$151.00 million$154.54 millionViewListenView Earnings Details
2/17/2015Q414$0.37$0.40$159.45 million$161.80 millionViewListenView Earnings Details
10/29/2014Q314$0.25$0.27$144.20 million$144.10 millionViewListenView Earnings Details
8/7/2014Q214$0.29$0.27$145.76 million$140.92 millionViewListenView Earnings Details
4/30/2014Q114$0.29$0.39$144.01 million$139.80 millionViewListenView Earnings Details
2/13/2014Q413$0.31$0.31$148.25 million$134.70 millionViewListenView Earnings Details
10/30/2013Q313$0.26$0.27$132.47 million$131.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.28$0.30$136.36 million$137.42 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.28$0.28$134.46 million$135.90 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.29$0.26$129.09 million$132.20 millionViewListenView Earnings Details
11/1/2012Q312$0.26$0.26$120.99 million$112.10 millionViewN/AView Earnings Details
8/1/2012$0.28$0.27ViewN/AView Earnings Details
5/2/2012$0.28$0.27ViewN/AView Earnings Details
2/14/2012$0.23$0.23ViewN/AView Earnings Details
10/25/2011$0.27$0.24ViewN/AView Earnings Details
8/9/2011$0.28$0.28ViewN/AView Earnings Details
5/3/2011$0.30$0.30ViewN/AView Earnings Details
2/15/2011$0.26$0.29ViewN/AView Earnings Details
11/2/2010Q3 2010$0.25$0.27ViewN/AView Earnings Details
8/3/2010Q2 2010$0.25$0.25ViewN/AView Earnings Details
5/4/2010Q1 2010$0.23$0.24ViewN/AView Earnings Details
2/16/2010Q4 2009$0.22$0.23ViewN/AView Earnings Details
11/3/2009Q3 2009$0.21$0.22ViewN/AView Earnings Details
8/4/2009Q2 2009$0.21$0.22ViewN/AView Earnings Details
5/5/2009Q1 2009$0.19$0.22ViewN/AView Earnings Details
3/3/2009Q4 2008$0.18$0.24ViewN/AView Earnings Details
10/27/2008Q3 2008$0.16$0.22ViewN/AView Earnings Details
8/4/2008Q2 2008$0.14$0.18ViewN/AView Earnings Details
4/29/2008Q1 2008$0.11$0.15ViewN/AView Earnings Details
2/26/2008Q4 2007$0.13$0.18ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Masimo (NASDAQ:MASI) Earnings Estimates

2018 EPS Consensus Estimate: $2.53
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.63$0.63$0.63
Q2 20181$0.65$0.65$0.65
Q3 20181$0.64$0.64$0.64
Q4 20181$0.61$0.61$0.61
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Masimo (NASDAQ:MASI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Masimo (NASDAQ MASI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 16.60%
Institutional Ownership Percentage: 82.30%
Insider Trades by Quarter for Masimo (NASDAQ:MASI)
Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Masimo (NASDAQ MASI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/1/2018Sanford FitchDirectorSell2,000$93.07$186,140.0068,249View SEC Filing  
2/1/2018Yongsam LeeEVPSell10,000$92.95$929,500.0079,000View SEC Filing  
1/25/2018Sanford FitchDirectorSell2,000$90.00$180,000.0070,249View SEC Filing  
1/5/2018Yongsam LeeEVPSell10,000$88.17$881,700.0075,018View SEC Filing  
12/4/2017Yongsam LeeEVPSell18,198$88.85$1,616,892.3070,800View SEC Filing  
12/1/2017Yongsam LeeEVPSell5,900$88.31$521,029.0070,800View SEC Filing  
11/9/2017Yongsam LeeEVPSell13,976$89.43$1,249,873.6874,000View SEC Filing  
11/1/2017Steven BarkerDirectorSell10,000$90.00$900,000.0073,249View SEC Filing  
11/1/2017Yongsam LeeEVPSell5,000$89.89$449,450.0074,000View SEC Filing  
8/17/2017Sanford FitchDirectorSell11,000$87.25$959,750.0072,249View SEC Filing  
7/20/2017Jon ColemanInsiderSell25,000$97.50$2,437,500.0032,201View SEC Filing  
7/14/2017Rick FishelInsiderSell15,000$94.85$1,422,750.0035,022View SEC Filing  
7/13/2017Sanford FitchDirectorSell6,000$91.89$551,340.0089,249View SEC Filing  
7/11/2017Anand SampathCOOSell40,000$92.00$3,680,000.0020,000View SEC Filing  
7/11/2017Rick FishelInsiderSell15,000$92.85$1,392,750.0035,022View SEC Filing  
6/29/2017Sanford FitchDirectorSell14,000$92.06$1,288,840.0090,249View SEC Filing  
5/1/2017Joe E KianiCEOSell145,841$102.37$14,929,743.17165,082View SEC Filing  
4/28/2017Thomas Samuel McclenahanEVPSell8,000$102.75$822,000.002,000View SEC Filing  
4/26/2017Joe E KianiCEOSell154,159$99.70$15,369,652.30219,241View SEC Filing  
4/25/2017Joe E KianiCEOSell13,201$101.00$1,333,301.00219,241View SEC Filing  
4/25/2017Jon ColemanInsiderSell50,000$100.00$5,000,000.0014,682View SEC Filing  
4/25/2017Yongsam LeeEVPSell10,000$100.00$1,000,000.0079,000View SEC Filing  
4/24/2017Joe E KianiCEOSell100,000$99.00$9,900,000.00219,241View SEC Filing  
4/24/2017Thomas Samuel McclenahanEVPSell10,000$98.75$987,500.0010,000View SEC Filing  
4/20/2017Thomas Samuel McclenahanEVPSell10,000$95.75$957,500.004,000View SEC Filing  
4/19/2017Yongsam LeeEVPSell10,000$95.00$950,000.0079,000View SEC Filing  
4/4/2017Raad Mark DeCFOSell48,000$93.25$4,476,000.0014,660View SEC Filing  
3/22/2017Sanford FitchDirectorSell3,000$93.23$279,690.0080,000View SEC Filing  
3/10/2017Paul JansenEVPSell55,611$94.47$5,253,571.1710,000View SEC Filing  
3/9/2017Ramshorst David J VanInsiderSell7,500$94.20$706,500.002,500View SEC Filing  
2/23/2017Raad Mark DeCFOSell30,000$86.25$2,587,500.0017,660View SEC Filing  
2/17/2017Raad Mark DeCFOSell45,000$80.00$3,600,000.0017,660View SEC Filing  
2/16/2017Joe E KianiCEOSell300,000$80.04$24,012,000.00119,241View SEC Filing  
2/3/2017Jon ColemanInsiderSell6,000$75.00$450,000.0013,182View SEC Filing  
2/3/2017Raad Mark DeCFOSell15,000$75.00$1,125,000.0017,660View SEC Filing  
1/27/2017Jon ColemanInsiderSell5,800$72.50$420,500.008,707View SEC Filing  
1/27/2017Raad Mark DeCFOSell15,000$72.50$1,087,500.0017,660View SEC Filing  
1/20/2017Jon ColemanInsiderSell200$72.50$14,500.007,282View SEC Filing  
1/13/2017Yongsam LeeEVPSell10,000$72.00$720,000.0079,000View SEC Filing  
1/10/2017Jon ColemanInsiderSell6,000$70.00$420,000.0013,182View SEC Filing  
1/10/2017Raad Mark DeCFOSell15,000$70.00$1,050,000.0017,660View SEC Filing  
1/10/2017Yongsam LeeEVPSell10,000$70.00$700,000.0079,000View SEC Filing  
1/9/2017Paul JansenEVPSell17,945$68.88$1,236,051.6017,945View SEC Filing  
1/3/2017Ramshorst David J VanInsiderSell4,000$67.20$268,800.005,000View SEC Filing  
12/27/2016Paul JansenEVPSell2,055$68.88$141,548.402,055View SEC Filing  
12/21/2016Jon ColemanInsiderSell4,000$67.50$270,000.004,459View SEC Filing  
12/16/2016Thomas Samuel McclenahanEVPSell10,000$66.00$660,000.0010,000View SEC Filing  
12/8/2016Paul JansenEVPSell10,000$63.88$638,800.005,000View SEC Filing  
12/7/2016Thomas Samuel McclenahanEVPSell2,293$63.00$144,459.004,000View SEC Filing  
12/6/2016Joe E KianiCEOSell52,859$62.03$3,278,843.77119,241View SEC Filing  
12/6/2016Thomas Samuel McclenahanEVPSell4,000$63.00$252,000.004,000View SEC Filing  
12/1/2016Joe E KianiCEOSell36,119$62.06$2,241,545.14119,241View SEC Filing  
11/29/2016Joe E KianiCEOSell104,870$62.27$6,530,254.90119,241View SEC Filing  
11/23/2016Joe E KianiCEOSell85,771$62.06$5,322,948.26119,241View SEC Filing  
11/22/2016Joe E KianiCEOSell869$62.00$53,878.00119,241View SEC Filing  
11/21/2016Joe E KianiCEOSell30,462$62.04$1,889,862.48119,241View SEC Filing  
11/18/2016Joe E KianiCEOSell20,381$62.02$1,264,029.62119,241View SEC Filing  
11/1/2016Anand SampathCOOSell65,000$55.04$3,577,600.0023,171View SEC Filing  
10/31/2016Anand SampathCOOSell51,345$55.05$2,826,542.2523,171View SEC Filing  
10/19/2016Sanford FitchDirectorSell2,000$59.05$118,100.0046,000View SEC Filing  
10/10/2016Joe E KianiCEOSell84,617$60.26$5,099,020.42126,450View SEC Filing  
10/10/2016Yongsam LeeEVPSell30,000$60.50$1,815,000.0093,000View SEC Filing  
10/5/2016Sanford FitchDirectorSell2,000$59.58$119,160.0048,000View SEC Filing  
10/4/2016Joe E KianiCEOSell4,300$60.07$258,301.00121,441View SEC Filing  
10/3/2016Joe E KianiCEOSell2,200$60.00$132,000.00121,441View SEC Filing  
9/30/2016Thomas Samuel McclenahanEVPSell10,000$59.00$590,000.0010,000View SEC Filing  
9/27/2016Joe E KianiCEOSell4,464$60.01$267,884.64123,705View SEC Filing  
9/22/2016Joe E KianiCEOSell49,484$60.18$2,977,947.12158,911View SEC Filing  
9/21/2016Sanford FitchDirectorSell2,000$59.41$118,820.0050,000View SEC Filing  
9/20/2016Joe E KianiCEOSell400$60.16$24,064.00120,240View SEC Filing  
9/19/2016Joe E KianiCEOSell999$60.03$59,969.97120,240View SEC Filing  
9/7/2016Joe E KianiCEOSell33,536$60.00$2,012,160.00152,777View SEC Filing  
9/7/2016Jon ColemanInsiderSell6,000$60.00$360,000.00759View SEC Filing  
9/7/2016Sanford FitchDirectorSell2,000$59.81$119,620.00View SEC Filing  
8/17/2016Sanford FitchDirectorSell2,000$58.11$116,220.0054,000View SEC Filing  
8/4/2016Jon ColemanInsiderSell22,000$56.82$1,250,040.0010,459View SEC Filing  
8/4/2016Paul JansenEVPSell10,000$58.88$588,800.0010,000View SEC Filing  
8/3/2016Sanford FitchDirectorSell2,000$52.62$105,240.0056,000View SEC Filing  
7/20/2016Rick FishelInsiderSell22,000$53.85$1,184,700.0042,022View SEC Filing  
7/20/2016Sanford FitchDirectorSell3,000$53.48$160,440.0058,000View SEC Filing  
6/30/2016Ramshorst David J VanCAOSell5,000$52.50$262,500.003,000View SEC Filing  
6/7/2016Joe E KianiCEOSell65,048$50.00$3,252,400.00175,818View SEC Filing  
6/3/2016Joe E KianiCEOSell234,952$50.09$11,768,745.68313,797View SEC Filing  
6/1/2016Jon ColemanInsiderSell4,000$50.00$200,000.004,459View SEC Filing  
5/31/2016Raad Mark DeCFOSell40,000$49.43$1,977,200.0042,660View SEC Filing  
5/25/2016Rick FishelInsiderSell25,000$49.85$1,246,250.0052,022View SEC Filing  
5/5/2016Jon ColemanInsiderSell8,000$47.00$376,000.004,459View SEC Filing  
4/28/2016Paul JansenEVPSell10,000$44.88$448,800.0010,000View SEC Filing  
4/27/2016Jon ColemanInsiderSell4,000$44.00$176,000.004,459View SEC Filing  
3/23/2016Yongsam LeeEVPSell96,000$39.96$3,836,160.00133,000View SEC Filing  
3/22/2016Yongsam LeeEVPSell32,000$40.06$1,281,920.00133,000View SEC Filing  
3/21/2016Yongsam LeeEVPSell32,000$39.83$1,274,560.00133,000View SEC Filing  
3/15/2016Raad Mark DeCFOSell40,000$39.00$1,560,000.0042,660View SEC Filing  
2/29/2016Raad Mark DeCFOSell40,000$38.11$1,524,400.0042,660View SEC Filing  
12/24/2015Jon ColemaninsiderSell10,000$42.00$420,000.00459View SEC Filing  
12/9/2015Sanford FitchDirectorSell2,000$41.00$82,000.0061,000View SEC Filing  
11/11/2015Sanford FitchDirectorSell2,000$42.67$85,340.0061,000View SEC Filing  
11/6/2015Anand SampathCOOSell45,000$42.00$1,890,000.00View SEC Filing  
11/6/2015Jon ColemaninsiderSell10,000$42.38$423,800.00459View SEC Filing  
10/14/2015Sanford FitchDirectorSell2,000$39.29$78,580.0061,000View SEC Filing  
9/17/2015Paul JansenEVPSell10,000$42.88$428,800.00View SEC Filing  
9/9/2015Sanford FitchDirectorSell2,000$41.29$82,580.0061,000View SEC Filing  
8/31/2015Thomas Samuel McclenahanEVPSell22,000$40.62$893,640.00View SEC Filing  
8/26/2015Paul JansenEVPSell10,000$40.88$408,800.00View SEC Filing  
7/22/2015Rick FishelInsiderSell35,084$41.85$1,468,265.40View SEC Filing  
7/21/2015Joe E KianiCEOSell300,000$40.55$12,165,000.00View SEC Filing  
7/21/2015Steven BarkerDirectorSell20,000$40.00$800,000.00View SEC Filing  
7/8/2015Sanford FitchDirectorSell2,000$38.18$76,360.00View SEC Filing  
6/10/2015Sanford FitchDirectorSell2,000$36.49$72,980.00View SEC Filing  
6/4/2015Steven BarkerDirectorSell25,000$36.20$905,000.00View SEC Filing  
4/8/2015Sanford FitchDirectorSell2,000$34.57$69,140.00View SEC Filing  
2/18/2015Rick FishelInsiderSell18,170$29.85$542,374.50View SEC Filing  
5/22/2013Robert ColemanDirectorSell59,400$21.93$1,302,642.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Masimo (NASDAQ MASI) News Headlines

Source:
DateHeadline
Masimo Co. (MASI) Receives Consensus Rating of "Hold" from BrokeragesMasimo Co. (MASI) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - February 17 at 3:38 AM
New Study Evaluates the Performance of Masimo PVi® as a ... - Business Wire (press release)New Study Evaluates the Performance of Masimo PVi® as a ... - Business Wire (press release)
www.businesswire.com - February 12 at 3:18 PM
 Brokerages Anticipate Masimo Co. (MASI) Will Post Quarterly Sales of $201.63 Million Brokerages Anticipate Masimo Co. (MASI) Will Post Quarterly Sales of $201.63 Million
www.americanbankingnews.com - February 11 at 2:08 AM
Masimo's (MASI) Eve Gets CE Mark, Bolsters CCHD DiagnosisMasimo's (MASI) Eve Gets CE Mark, Bolsters CCHD Diagnosis
finance.yahoo.com - February 8 at 3:18 PM
Masimo Announces CE Marking of Eve™ CCHD Newborn Screening Application for the Rad-97™ Pulse CO-Oximeter - Business Wire (press release)Masimo Announces CE Marking of Eve™ CCHD Newborn Screening Application for the Rad-97™ Pulse CO-Oximeter - Business Wire (press release)
www.businesswire.com - February 8 at 5:28 AM
Masimo (MASI) Lowered to Hold at Zacks Investment ResearchMasimo (MASI) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - February 7 at 1:18 PM
Masimo Announces CE Marking of Eve™ CCHD Newborn Screening Application for the Rad-97™ Pulse CO-Oximeter®Masimo Announces CE Marking of Eve™ CCHD Newborn Screening Application for the Rad-97™ Pulse CO-Oximeter®
finance.yahoo.com - February 7 at 5:43 AM
Masimo Co. (MASI) Director Sanford Fitch Sells 2,000 SharesMasimo Co. (MASI) Director Sanford Fitch Sells 2,000 Shares
www.americanbankingnews.com - February 2 at 9:44 PM
Masimo Co. (MASI) EVP Sells $929,500.00 in StockMasimo Co. (MASI) EVP Sells $929,500.00 in Stock
www.americanbankingnews.com - February 2 at 9:26 PM
Masimo to Report Fourth Quarter and Full Year 2017 Financial Results after Market Close on Tuesday, February 27Masimo to Report Fourth Quarter and Full Year 2017 Financial Results after Market Close on Tuesday, February 27
finance.yahoo.com - January 31 at 3:18 PM
Masimo to Report Fourth Quarter and Full Year 2017 Financial Results after Market Close on Tuesday, February 27 - Business Wire (press release)Masimo to Report Fourth Quarter and Full Year 2017 Financial Results after Market Close on Tuesday, February 27 - Business Wire (press release)
www.businesswire.com - January 30 at 3:17 PM
Masimo Announces FDA Clearance of Next Generation SedLine - Business Wire (press release)Masimo Announces FDA Clearance of Next Generation SedLine - Business Wire (press release)
www.businesswire.com - January 30 at 5:37 AM
Masimo Announces FDA Clearance of Next Generation SedLine® Brain Function MonitoringMasimo Announces FDA Clearance of Next Generation SedLine® Brain Function Monitoring
finance.yahoo.com - January 29 at 3:18 PM
Short Interest in Masimo Co. (MASI) Decreases By 26.3%Short Interest in Masimo Co. (MASI) Decreases By 26.3%
www.americanbankingnews.com - January 29 at 1:40 AM
Sanford Fitch Sells 2,000 Shares of Masimo Co. (MASI) StockSanford Fitch Sells 2,000 Shares of Masimo Co. (MASI) Stock
www.americanbankingnews.com - January 26 at 9:28 PM
Masimo Co. (MASI) Expected to Announce Quarterly Sales of $201.63 MillionMasimo Co. (MASI) Expected to Announce Quarterly Sales of $201.63 Million
www.americanbankingnews.com - January 25 at 1:40 AM
 Brokerages Expect Masimo Co. (MASI) to Post $0.61 Earnings Per Share Brokerages Expect Masimo Co. (MASI) to Post $0.61 Earnings Per Share
www.americanbankingnews.com - January 23 at 9:26 PM
Masimo Co. (MASI) Given Consensus Recommendation of "Hold" by AnalystsMasimo Co. (MASI) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - January 23 at 3:46 AM
New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients - Business Wire (press release)New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™, in Obese Patients - Business Wire (press release)
www.businesswire.com - January 22 at 7:46 AM
6 Companies Growing Revenue and Earnings6 Companies Growing Revenue and Earnings
finance.yahoo.com - January 17 at 5:19 PM
President Clinton to Address Healthcare Leaders Focused on Eliminating Preventable Deaths in Hospitals at the 6th Annual World Patient Safety, Science & Technology SummitPresident Clinton to Address Healthcare Leaders Focused on Eliminating Preventable Deaths in Hospitals at the 6th Annual World Patient Safety, Science & Technology Summit
www.businesswire.com - January 17 at 9:31 AM
Masimo Gets FDA Nod for Rad-97, Enables Healthcare at Home ... - NasdaqMasimo Gets FDA Nod for Rad-97, Enables Healthcare at Home ... - Nasdaq
www.nasdaq.com - January 12 at 5:00 PM
Masimo Corp. (MASI) Announces FDA Clearance for Home Use of Rad-97Masimo Corp. (MASI) Announces FDA Clearance for Home Use of Rad-97
www.streetinsider.com - January 10 at 9:45 AM
Masimo Announces FDA Clearance for Home Use of Rad-97™Masimo Announces FDA Clearance for Home Use of Rad-97™
finance.yahoo.com - January 9 at 9:40 AM
Yongsam Lee Sells 10,000 Shares of Masimo Co. (MASI) StockYongsam Lee Sells 10,000 Shares of Masimo Co. (MASI) Stock
www.americanbankingnews.com - January 8 at 6:50 PM
Zacks: Analysts Anticipate Masimo Co. (MASI) to Announce $0.61 EPSZacks: Analysts Anticipate Masimo Co. (MASI) to Announce $0.61 EPS
www.americanbankingnews.com - January 6 at 5:10 PM
ZOLL Propaq M Selected by U.S. Air Force and U.S. Army as Their Deployable Vital Signs MonitorZOLL Propaq M Selected by U.S. Air Force and U.S. Army as Their Deployable Vital Signs Monitor
www.businesswire.com - January 5 at 4:57 PM
Masimo to Present at 36th Annual J.P. Morgan Healthcare ConferenceMasimo to Present at 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 5:13 PM
Masimo (MASI) Stock Rating Lowered by Zacks Investment ResearchMasimo (MASI) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - January 3 at 10:18 AM
Robust Pipeline Aids Edwards Lifesciences, Rising Costs AilRobust Pipeline Aids Edwards Lifesciences, Rising Costs Ail
finance.yahoo.com - December 29 at 10:12 AM
Masimo Co. (MASI) Receives Consensus Rating of "Hold" from AnalystsMasimo Co. (MASI) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - December 29 at 4:28 AM
ETFs with exposure to Masimo Corp. : December 27, 2017ETFs with exposure to Masimo Corp. : December 27, 2017
finance.yahoo.com - December 28 at 8:32 AM
$201.63 Million in Sales Expected for Masimo Co. (MASI) This Quarter$201.63 Million in Sales Expected for Masimo Co. (MASI) This Quarter
www.americanbankingnews.com - December 23 at 8:30 AM
 Analysts Anticipate Masimo Co. (MASI) to Announce $0.61 Earnings Per Share Analysts Anticipate Masimo Co. (MASI) to Announce $0.61 Earnings Per Share
www.americanbankingnews.com - December 21 at 11:24 AM
Masimo Corp. breached its 50 day moving average in a Bullish Manner : MASI-US : December 18, 2017Masimo Corp. breached its 50 day moving average in a Bullish Manner : MASI-US : December 18, 2017
finance.yahoo.com - December 18 at 9:59 AM
ETFs with exposure to Masimo Corp. : December 14, 2017ETFs with exposure to Masimo Corp. : December 14, 2017
finance.yahoo.com - December 14 at 5:43 PM
Masimo Corp. – Value Analysis (NASDAQ:MASI) : December 12, 2017Masimo Corp. – Value Analysis (NASDAQ:MASI) : December 12, 2017
finance.yahoo.com - December 12 at 5:36 PM
Masimo (MASI) Downgraded to "Sell" at BidaskClubMasimo (MASI) Downgraded to "Sell" at BidaskClub
www.americanbankingnews.com - December 9 at 1:38 PM
Masimo Corp. breached its 50 day moving average in a Bearish Manner : MASI-US : December 8, 2017Masimo Corp. breached its 50 day moving average in a Bearish Manner : MASI-US : December 8, 2017
finance.yahoo.com - December 8 at 9:40 AM
Free Research Report as Masimo’s Revenue Jumped 15.6%; EPS Surged 35%Free Research Report as Masimo’s Revenue Jumped 15.6%; EPS Surged 35%
finance.yahoo.com - December 8 at 9:40 AM
Insider Selling: Masimo Co. (MASI) EVP Sells 5,900 Shares of StockInsider Selling: Masimo Co. (MASI) EVP Sells 5,900 Shares of Stock
www.americanbankingnews.com - December 4 at 9:02 PM
Masimo Co. (MASI) EVP Sells $1,616,892.30 in StockMasimo Co. (MASI) EVP Sells $1,616,892.30 in Stock
www.americanbankingnews.com - December 4 at 8:38 PM
Artemis Hospital Becomes First in India to Adopt Masimo Patient SafetyNet™ Across All Hospital Care Areas - Business Wire (press release)Artemis Hospital Becomes First in India to Adopt Masimo Patient SafetyNet™ Across All Hospital Care Areas - Business Wire (press release)
www.businesswire.com - December 3 at 5:11 PM
Masimo Corp. (MASI) Reports FDA Clearance and Worldwide Release of NomoLine Capnography Sampling LinesMasimo Corp. (MASI) Reports FDA Clearance and Worldwide Release of NomoLine Capnography Sampling Lines
www.streetinsider.com - November 27 at 5:01 PM
Masimo Announces FDA Clearance and Worldwide Release of NomoLine™ Capnography Sampling LinesMasimo Announces FDA Clearance and Worldwide Release of NomoLine™ Capnography Sampling Lines
finance.yahoo.com - November 27 at 5:01 PM
5 MedTech Stocks to Beat Tax Hazards With Positive Returns5 MedTech Stocks to Beat Tax Hazards With Positive Returns
finance.yahoo.com - November 27 at 5:01 PM
Heres Why You Should Invest in Masimo (MASI) Right Now - NasdaqHere's Why You Should Invest in Masimo (MASI) Right Now - Nasdaq
www.nasdaq.com - November 24 at 5:17 PM
 Analysts Expect Masimo Corporation (MASI) Will Post Quarterly Sales of $201.63 Million Analysts Expect Masimo Corporation (MASI) Will Post Quarterly Sales of $201.63 Million
www.americanbankingnews.com - November 17 at 3:52 PM
ETFs with exposure to Masimo Corp. : November 17, 2017ETFs with exposure to Masimo Corp. : November 17, 2017
finance.yahoo.com - November 17 at 2:53 PM
Masimo Corporations (MASI) Stifel 2017 Healthcare Brokers Conference (Transcript)Masimo Corporation's (MASI) Stifel 2017 Healthcare Brokers Conference (Transcript)
seekingalpha.com - November 15 at 6:13 AM

SEC Filings

Masimo (NASDAQ:MASI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Masimo (NASDAQ:MASI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Masimo (NASDAQ MASI) Stock Chart for Saturday, February, 17, 2018

Loading chart…

This page was last updated on 2/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.